We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Human Samples and Data Repository

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00539370
Recruitment Status : Completed
First Posted : October 4, 2007
Last Update Posted : June 14, 2012
Information provided by:

Study Description
Brief Summary:

This protocol will enable IRB (institutional review board) review of proposed research using human samples and data collected under the terminated NIH studies 04-EI-0065 and 96-EI-0096. Data and samples may include demographic and personal health information, psychological or psychiatric testing, blood, urine, CSF or other body fluids or tissues and results of medical and physiological evaluation and medical imaging.

Data and sample analyses are limited to those approved under the original protocols unless additional specific institutional review board approval is obtained.

Condition or disease
Uveitis Scleritis

Detailed Description:

Objective: This protocol will enable prospective IRB review of research using human samples and data collected under other branch protocols.

Study population: Participants that were followed in terminated branch protocols under which data or samples were collected.

Design: Samples and data will be brought under this protocol, analyzed and stored for uses specified in the original protocols and as additionally approved by the IRB.

Outcome: The outcome of this protocol will be the storage, tracking, and utilization of samples and data obtained under terminated protocols.

Study Design

Study Type : Observational
Estimated Enrollment : 0 participants
Time Perspective: Prospective
Official Title: Laboratory of Immunology/National Eye Institute Repository
Study Start Date : August 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Eye Care
U.S. FDA Resources

Groups and Cohorts

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
  • Data Analysis Study
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00539370

United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
National Eye Institute (NEI)
Principal Investigator: Robert B Nussenblatt, M.D. National Eye Institute (NEI)
More Information

Additional Information:
ClinicalTrials.gov Identifier: NCT00539370     History of Changes
Other Study ID Numbers: 070213
First Posted: October 4, 2007    Key Record Dates
Last Update Posted: June 14, 2012
Last Verified: June 2012

Keywords provided by National Institutes of Health Clinical Center (CC):
Intermediate Uveitis
Posterior Uveitis
Intraocular Inflammatory Disease
Data Analysis
Data Collection
Sample Analysis

Additional relevant MeSH terms:
Uveal Diseases
Eye Diseases
Scleral Diseases